Twist Bioscience Corporation
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2017 | — | — | $31.2M |
| Dec 2017 | — | — | $26.3M |
| Mar 2018 | — | — | $78.6M |
| Jun 2018 | — | — | $91.1M |
| Sep 2018 | $26.7M | $115.8M | $80.8M |
| Dec 2018 | $25.9M | $164.5M | $66.5M |
| Mar 2019 | $24.7M | $140.2M | $28.7M |
| Jun 2019 | $30.8M | $206.8M | $68.2M |
| Sep 2019 | $34.9M | $187.0M | $46.7M |
| Dec 2019 | $89.2M | $192.3M | $26.0M |
| Mar 2020 | $59.7M | $323.9M | $184.4M |
| Jun 2020 | $59.3M | $408.2M | $207.9M |
| Sep 2020 | $62.6M | $398.9M | $93.7M |
| Dec 2020 | $61.6M | $699.6M | $348.8M |
| Mar 2021 | $63.1M | $677.3M | $399.3M |
| Jun 2021 | $114.9M | $725.3M | $475.3M |
| Sep 2021 | $121.3M | $702.1M | $465.8M |
| Dec 2021 | $160.0M | $786.2M | $191.6M |
| Mar 2022 | $158.3M | $1.02B | $407.6M |
| Jun 2022 | $159.0M | $979.7M | $376.2M |
| Sep 2022 | $172.0M | $961.4M | $378.7M |
| Dec 2022 | $163.6M | $910.0M | $316.7M |
| Mar 2023 | $150.0M | $853.9M | $315.2M |
| Jun 2023 | $152.8M | $810.3M | $307.5M |
| Sep 2023 | $153.0M | $776.4M | $286.5M |
| Dec 2023 | $142.8M | $732.8M | $266.3M |
| Mar 2024 | $142.7M | $702.8M | $243.3M |
| Jun 2024 | $147.0M | $638.1M | $239.1M |
| Sep 2024 | $141.6M | $614.3M | $226.3M |
| Dec 2024 | $152.6M | $608.6M | $221.4M |
| Mar 2025 | $155.5M | $595.6M | $210.4M |
| Jun 2025 | $165.4M | $643.6M | $201.4M |
| Sep 2025 | $168.9M | $641.9M | $183.0M |
| Dec 2025 | $182.0M | $638.1M | $148.6M |
| Mar 2026 | $221.1M | $676.2M | $122.7M |
| Jun 2026 | $226.7M | $672.4M | $117.4M |